EXPO stock icon

Exponent

113.37 USD
-1.16
1.01%
At close Oct 17, 4:00 PM EDT
After hours
113.37
+0.00
0.00%
1 day
-1.01%
5 days
2.54%
1 month
4.63%
3 months
7.92%
6 months
45.85%
Year to date
24.71%
1 year
26.50%
5 years
60.13%
 

About: Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

Employees: 1,320

0
Funds holding %
of 6,740 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

5,382% more call options, than puts

Call options by funds: $2.08M | Put options by funds: $38K

97% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 29

50% more funds holding in top 10

Funds holding in top 10: 2 [Q1] → 3 (+1) [Q2]

22% more repeat investments, than reductions

Existing positions increased: 144 | Existing positions reduced: 118

14% more capital invested

Capital invested by funds: $3.87B [Q1] → $4.43B (+$560M) [Q2]

9% more funds holding

Funds holding: 322 [Q1] → 350 (+28) [Q2]

0.56% less ownership

Funds ownership: 92.47% [Q1] → 91.9% (-0.56%) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$120
6%
upside
Avg. target
$120
6%
upside
High target
$120
6%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Truist Securities
Tobey Sommer
85% 1-year accuracy
29 / 34 met price target
6%upside
$120
Buy
Reiterated
26 Jul 2024

Financial journalist opinion

Charts implemented using Lightweight Charts™